Tianjin Lisheng Pharmaceutical (002393) posted an 81.3 percent year-on-year increase in first half 2011 preliminary net profit to 239 million yuan, with earnings per share (EPS) of 1.31 yuan, reports stcn.com, citing a company filing.
Sales revenue rose 16.23 percent year-on-year to 456 million yuan.
According to the company, operating profit, total profit, net profit and EPS increased by more than 30 percent on average due mainly to the returns from the transfer of a 25 percent stake in Tianjin Wutian Pharmaceutical during the reporting period.
